Larkin Health System

Healthcare delivery system

Based in FL

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $80K in lobbying spend across 5 quarterly filings, Larkin Health System is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.

$80K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$80K
2025$0

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

BGR Government Affairs

Lobbyists

Daniel Farmer

Government Agencies Targeted

These are the government entities that Larkin Health System disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)HOUSE OF REPRESENTATIVES
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

Provide strategic counsel and advocate on issues related to Medicare payment for hospitals.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Apotex Corp.
$9.0M total spend
Blue Cross and Blue Shield of Florida INC
$7.4M total spend
Baycare Health System
$6.8M total spend
Vitas Healthcare Corporation
$3.9M total spend
Lincare
$2.6M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.